Acrivon Therapeutics, Inc. (ACRV)
Data as of , from SEC Form 4 filings.
See up to 3 months of ACRV. The 7-day demo opens the 1M and 3M ranges and puts ACRV on your watchlist.
Start 7-day demoLatest ACRV insider trades
Mary Miller - OfficerOpen-market sale$585- Peter Blume-Jensen - OfficerOpen-market sale$31K
About Acrivon Therapeutics, Inc. (ACRV)
The SEC lists Acrivon Therapeutics, Inc. under CIK 0001781174, in pharmaceutical preparations. It is grouped with Health Care companies on this site.
ACRV Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 10 | 19,048 | $40K |
| Grant or award | 2 | 160,000 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
ACRV insider transactions (Form 4)
3790 Form 4 filings on record, the earliest from Oct 3, 2024, newest first. Filing history page 3 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Eric Devroe - Officer | Tax withholding / forfeiture | Common Stock | 613 | $2.24 | $1K | |
| Peter Blume-Jensen - Officer | Tax withholding / forfeiture | Common Stock | 59,765 | $2.24 | $134K | |
| Peter Blume-Jensen - Officer | Tax withholding / forfeiture | Common Stock | 490 | $2.24 | $1K | |
| Mary Miller - Officer | Tax withholding / forfeiture | Common Stock | 558 | $1.81 | $1K | |
| Mary Miller - Officer | Tax withholding / forfeiture | Common Stock | 284 | $1.81 | $514 | |
| Mansoor Raza Mirza - Officer | Grant or award | Stock Option (Right to Buy) | 225,000 | $0.00 | - | |
| Peter Blume-Jensen - Officer | Tax withholding / forfeiture | Common Stock | 19,905 | $1.32 | $26K | |
| Katharine Peterson - Officer | Tax withholding / forfeiture | Common Stock | 99 | $1.39 | $138 | |
| Mary Miller - Officer | Tax withholding / forfeiture | Common Stock | 184 | $1.39 | $256 | |
| Erick Gamelin - Officer | Tax withholding / forfeiture | Common Stock | 403 | $1.39 | $560 | |
| Eric Devroe - Officer | Tax withholding / forfeiture | Common Stock | 613 | $1.39 | $852 | |
| Peter Blume-Jensen - Officer | Tax withholding / forfeiture | Common Stock | 59,766 | $1.39 | $83K | |
| Peter Blume-Jensen - Officer | Tax withholding / forfeiture | Common Stock | 490 | $1.39 | $681 | |
| Adam D. Levy - Officer | Tax withholding / forfeiture | Common Stock | 1,164 | $1.26 | $1K | |
| Mary Miller - Officer | Tax withholding / forfeiture | Common Stock | 558 | $1.32 | $737 | |
| Ivana Magovcevic-Liebisch | Grant or award | Stock Option (Right to Buy) | 20,275 | $0.00 | - | |
| PERCEPTIVE ADVISORS LLC - 10% Owner | Open-market sale | Common Stock | 437,881 | $1.41 | $617K | |
| PERCEPTIVE ADVISORS LLC - 10% Owner | Open-market sale | Common Stock | 298,886 | $1.34 | $401K | |
| PERCEPTIVE ADVISORS LLC - 10% Owner | Open-market sale | Common Stock | 1,054,669 | $1.95 | $2.06M | |
| PERCEPTIVE ADVISORS LLC - 10% Owner | Open-market sale | Common Stock | 215,283 | $1.56 | $336K | |
| PERCEPTIVE ADVISORS LLC - 10% Owner | Open-market sale | Common Stock | 250,000 | $1.41 | $353K | |
| Mary Miller - Officer | Grant or award | Stock Option (Right to Buy) | 67,567 | $0.00 | - | |
| Rasmus Holm-Jorgensen - Officer | Grant or award | Stock Option (Right to Buy) | 90,090 | $0.00 | - | |
| Erick Gamelin - Officer | Grant or award | Stock Option (Right to Buy) | 45,045 | $0.00 | - | |
| Eric Devroe - Officer | Grant or award | Stock Option (Right to Buy) | 90,090 | $0.00 | - | |
| Peter Blume-Jensen - Officer | Grant or award | Stock Option (Right to Buy) | 225,226 | $0.00 | - | |
| Peter Blume-Jensen - Officer | Grant or award | Stock Option (Right to Buy) | 90,090 | $0.00 | - | |
| Peter Blume-Jensen - Officer | Tax withholding / forfeiture | Common Stock | 19,910 | $6.44 | $128K | |
| Katharine Peterson - Officer | Tax withholding / forfeiture | Common Stock | 99 | $7.92 | $784 | |
| Mary Miller - Officer | Tax withholding / forfeiture | Common Stock | 184 | $7.92 | $1K | |
| Rasmus Holm-Jorgensen - Officer | Tax withholding / forfeiture | Common Stock | 368 | $7.92 | $3K | |
| Erick Gamelin - Officer | Tax withholding / forfeiture | Common Stock | 402 | $7.92 | $3K | |
| Eric Devroe - Officer | Tax withholding / forfeiture | Common Stock | 613 | $7.92 | $5K | |
| Peter Blume-Jensen - Officer | Tax withholding / forfeiture | Common Stock | 59,766 | $7.92 | $473K | |
| Peter Blume-Jensen - Officer | Tax withholding / forfeiture | Common Stock | 490 | $7.92 | $4K | |
| Mary Miller - Officer | Tax withholding / forfeiture | Common Stock | 558 | $7.87 | $4K | |
| Mary Miller - Officer | Tax withholding / forfeiture | Common Stock | 284 | $6.98 | $2K |
Recent ACRV Form 144 notices of proposed sale
1An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| Peter Blume-Jensen | Officer, Director | 14,036 | $31K | View on EDGAR |
ACRV insider trading FAQ
What is the latest insider trade for ACRV?
Acrivon Therapeutics, Inc. (ACRV) had 10 insider filings in the last 90 days, with the most recent on 2026-10-07. The full record for ACRV runs to 90 Form 4 filings, the earliest from 2024-10-03. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying ACRV stock?
No insider purchases of ACRV were filed in the last 90 days. 3 purchases are on record for this company.
How many insiders are selling ACRV stock?
10 insider sales of ACRV were filed in the last 90 days, totaling $40K.
Where can I see ACRV SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects ACRV Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Mary Miller view on EDGAR
- - Michaela Levin view on EDGAR
- - Peter Blume-Jensen view on EDGAR
- - Katharine Peterson view on EDGAR
- - Mary Miller view on EDGAR
- - Erick Gamelin view on EDGAR
- - Eric Devroe view on EDGAR
- - Peter Blume-Jensen view on EDGAR
- - Adam D. Levy view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where ACRV's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow ACRV with a 7-day demo
- ACRV on your watchlist
- Every ACRV Form 4 filing on record
- Up to 3 months of ACRV price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
